Navigation Links
Walk Your Way to Better Health in 2009
Date:12/30/2008

iratory categories. Omron Healthcare markets clinically proven products that provide accurate health information to consumers and physicians and support positive lifestyle changes and health improvement.

(1) "Using Pedometers to Increase Physical Activity and Improve Health." Journal of the American Medical Association, November 2007.

     Contact:

     Lila Trickle
     Edelman for Omron Healthcare, Inc.
     (312) 233-1218
     lila.trickle@edelman.com

'/>"/>
SOURCE Omron Healthcare, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. New Product Makes Loose Dentures Fit Better
2. Coated Stents Better Than Bare Metal Ones in Short Run
3. Better patient outcomes with drug eluting stents
4. National rates of co-occurring substance use and mental disorders call for better service integration
5. Lower-dose fractionated stereotactic radiotherapy results in better hearing preservation
6. Immune System Works Better at Night
7. AmericInn Hotels Partners With Nationally Recognized Sleep Expert Dr. Christopher Drake, Announces Launch of Sleep Better America Campaign
8. Immunology Center will continue to drive standard methods, better science
9. Most Newer Antipsychotics No Better Than Older Ones, Just Different
10. Southern California Rehabilitation Clinic is Hiring Bilingual Therapists to Better Serve the Hispanic Communities of Mexico and the United States
11. Study shows school-based program enables children and adolescents to better manage chronic disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...NTURA,Fla.,Nov.25/PRNewswire/--DanielTouizer,CEOof...ranteedissuehealthinsurancebenefitprograms,isconce...bermeansnearlyoneinfiveAmericansarewithoutafull-ti...unemploymentratesaredeterminedbytheU-6number,which... Dani e l T ouizer ."Thesestatisticsarealarm...
(Date:11/25/2009)...ease is available in French and Spanish . ,... have provided an early diagnosis of certain ocul...e-related macular degeneration and keratitis, by a...heless, had never before been used for this purpos...image quality in subjects affected by one of these...
(Date:11/25/2009)...ss release is available in French . , , Mont... are about to enter the marketplace, thanks to a n...artnership (Univalor) and Cognitive Sensing Inc. (...n Montreal. , Univalor, which commercializes dis...iliated institutions, and CSI have announced the s...
(Date:11/25/2009)...n fruit fly study may lead to new drugs for people... (HealthDay News) -- Sphingadienes, natural lipid ...ent in treatments for colon cancer, California res...inary, but the study authors pointed out that they...ction against colon cancer. , In the study, Dr....
(Date:11/25/2009)... offer waistline-friendly ways to enjoy festive fe... News) -- If you love the five-week holiday smorga...eady stressing about the added pounds you,ll have ...,s possible, say nutrition experts, to enjoy holid...as you do today. , It,s all about devising a s...
Breaking Medicine News(10 mins):Health News:Cinergy Health Commentary on Health Care for the Unemployed 2Health News:Achieve early diagnosis of ocular pathologies such as keratitis and macular degeneration 2Health News:Univalor and Cognitive Sensing Inc. to commercialize 4 University of Montreal discoveries 2Health News:Natural Soy Component May Help Treat Colon Cancer 2Health News:Holiday Eating Without the Guilt -- or the Pounds 2Health News:Holiday Eating Without the Guilt -- or the Pounds 3
...-Year Growth Since Founded, YARDLEY, Pa., April 1...of corporate performance management solutions, tod... BTI has grown its services,revenue year- over-yea...technology or a,business process solution," said T...
...Civility Mutual, based in,Santa Fe, New Mexico, la...nization to offer education, training and CMEs for...and provides residency directors with the,educatio...gins with effective communication, driven by,respe...
...s April 15, 2008 Elderly patients who use antips...developing pneumonia compared to non-users. This r...ption and decreases gradually thereafter. These fi...f psychosis and behavioral problems associated wit...
... Open Biosystems, Inc.,focused on the commerciali... for drug discovery, today announced the availabil...or multiplexed RNAi screens. This,novel offering a...onal sequencing., (Logo: http://www.newscom.com/...
... /Xinhua-PRNewswire-FirstCall/ -- CNinsure,Inc. CI...kerage company,operating in China, today announced...ship with Minsheng Life Insurance Co., Ltd ("Minsh...d local branch,levels to further promote the busin...
..., 2008 -- Results of a phase IV, open label, head-...e, high-frequency subcutaneous Rebif (interferon b...gs show similar efficacy over 18 to 30 months of c...cal Research and Opinion journal. , The Prospecti...
Other Medicine News:Health News:Breakaway Technologies Celebrates 10 Years in Business 2Health News:New Health Care Company to Offer Training and CMEs on Physician - Patient Communications and Helps Fulfill ACGME Requirements 2Health News:Open Biosystems Launches Decode RNAi Viral Screening Pools for Low-Cost Genome-Scale RNAi Screens 2Health News:CNinsure Enters Into Strategic Partnership With Minsheng Life Insurance 2Health News:CNinsure Enters Into Strategic Partnership With Minsheng Life Insurance 3Health News:Study shows that high-dose, high-frequency interferon produces no additional benefit 2
(Date:11/24/2009)..., IRVINE,Calif.,Nov.24/PRNewswire-FirstCall/-...yinvasivetreatmentsforaorticdisorders,announcedtod...eedingsin,thepatentinfringementlawsuitbroughtagain...UnitedStatesDistrictCourtinIndianapolis,Indiana. ,...twhiletheUnitedStatesPatentandTrademarkOffice(USPT...
(Date:11/24/2009)..., FREMONT,Calif.,Nov.24/PRNewswire-FirstCall/...theCompanyfileditsPlanofReorganizationandDisclosur...sBankruptcyCourtfortheDistrictofDelaware.Ahearingt...lyscheduledforDecember8,2009,withthehearingontheco..., ThePlancallsfortheCompanytopayallclaimsinfull.Th...
(Date:11/24/2009)..., WOODCLIFFLAKE,N.J.andNEWYORK,Nov.24/PRNewsw...U.S.FoodandDrugAdministration(FDA)hasacceptedforre...Aricept®(donepezilHClextendedrelease)tabletsf...(AD).Thisnewhigherdoseformulationcontains23mgofdon...adeliverysystemthatallowsforgradualreleaseofthedru...
Breaking Medicine Technology:Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Blood flow metabolism mismatch predicts pancreatic tumor aggressiveness 9697 1Blood flow metabolism mismatch predicts pancreatic tumor aggressiveness 9697 2Schwarzeneggers Budget Cuts Force Closure of California AIDS Clearinghouse 55311 1Schwarzeneggers Budget Cuts Force Closure of California AIDS Clearinghouse 55311 2Minorities have poorer results higher rates of inappropriate surgery to prevent stroke 55308 1Minorities have poorer results higher rates of inappropriate surgery to prevent stroke 55308 2
...ll/ - AEterna Zentaris Inc.,(NASDAQ: AEZS ; TSX: ...n,endocrine therapy and oncology, today reported t...ruitment for its Phase 2 trial in ovarian cancer,w...one (LHRH) agonist,linked to doxorubicin. The deci...ent was taken following recent first stage data re...
...gual lozenge) developed to be the first sleep aid...hen patients awaken and have difficulty re...ranscept Pharmaceuticals,Inc., a privately-held sp...at it has submitted a New Drug Application (NDA) t...its lead product candidate, Intermezzo(R),(zolpide...
Other Medicine Technology:AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 2AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 3AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 4AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 5Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 2Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 3Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 4Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 5Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 6
BD Visitec Infusion Cannulas
BD Beaver™ Accurate Depth Knives
BD Visitec Irrigating Cystomes
BD Visitec Irrigation and Aspiration Cannulas
Medicine Products: